Acute myeloid leukemia cells exhibit selective down-regulation of DNMT3A isoform 2

Affiliations

Helen J S Stewart et al. Leuk Lymphoma. 2015.

. 2015;56(12):3445-8.

doi: 10.3109/10428194.2015.1032965. Epub 2015 Jun 19.

No abstract available

Similar articles

Deregulation of HOX genes by DNMT3A and MLL mutations converges on BMI1.
Tan YT, Sun Y, Zhu SH, Ye L, Zhao CJ, Zhao WL, Chen Z, Chen SJ, Liu H. Tan YT, et al. Leukemia. 2016 Jul;30(7):1609-12. doi: 10.1038/leu.2016.15. Epub 2016 Feb 8. Leukemia. 2016. PMID: 26854025 No abstract available.
DNMT3A in Leukemia.
Brunetti L, Gundry MC, Goodell MA. Brunetti L, et al. Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a030320. doi: 10.1101/cshperspect.a030320. Cold Spring Harb Perspect Med. 2017. PMID: 28003281 Free PMC article. Review.
DNMT3A R882 mutation is associated with elevated expression of MAFB and M4/M5 immunophenotype of acute myeloid leukemia blasts.
Yang L, Liu Y, Zhu L, Xiao M. Yang L, et al. Leuk Lymphoma. 2015;56(10):2914-22. doi: 10.3109/10428194.2015.1015123. Epub 2015 Jul 6. Leuk Lymphoma. 2015. PMID: 25721756
Acute myeloid leukemia with DNMT3A mutations.
Li Y, Zhu B. Li Y, et al. Leuk Lymphoma. 2014 Sep;55(9):2002-12. doi: 10.3109/10428194.2013.869802. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24283755 Review.
DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemia.
Bisling KE, Brewin JN, McGovern AP, Horne GA, Rider T, Stewart HJ, Ramsahoye BH, Chevassut TJ. Bisling KE, et al. Leuk Lymphoma. 2014 Mar;55(3):711-4. doi: 10.3109/10428194.2013.811580. Epub 2013 Jul 25. Leuk Lymphoma. 2014. PMID: 23741974 No abstract available.

HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents' combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model.
Alcitepe İ, Salcin H, Karatekin İ, Kaymaz BT. Alcitepe İ, et al. Med Oncol. 2022 Oct 12;39(12):257. doi: 10.1007/s12032-022-01858-x. Med Oncol. 2022. PMID: 36224430